BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment.
about
dbCoRC: a database of core transcriptional regulatory circuitries modeled by H3K27ac ChIP-seq signals.Acute Pharmacologic Degradation of a Stable Antigen Enhances Its Direct Presentation on MHC Class I Molecules.Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation.PAF1 regulation of promoter-proximal pause release via enhancer activation.Hexim1, an RNA-controlled protein hub.Bromodomian-containing protein 4-independent transcriptional activation by autoimmune regulator (AIRE) and NF-κB.Enhancer dysfunction in leukemia.Assessing sufficiency and necessity of enhancer activities for gene expression and the mechanisms of transcription activation.Derivatization of inhibitor of apoptosis protein (IAP) ligands yields improved inducers of estrogen receptor α degradation.The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AML.Multiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein Homeostasis.Benefit of Apabetalone on Plasma Proteins in Renal Disease.Targetable BET proteins- and E2F1-dependent transcriptional program maintains the malignancy of glioblastoma.Transcriptional targeting of oncogene addiction in medullary thyroid cancerPositive Regulation of Transcription by Human ZMYND8 through Its Association with P-TEFb ComplexPharmacological difference between degrader and inhibitor against oncogenic BCR-ABL kinase
P2860
Q46077296-11F64B3E-BE4C-4C4A-9C33-765C42A69901Q47718257-B7D3B50E-ABC8-445F-8AF0-6FA663D21496Q48100900-E9E96837-2DF8-45F4-A189-93C50DC61946Q48144442-4B1DF2C7-2FB7-4CED-B398-FEAB710B8975Q48219788-30A5131C-3DBC-4205-9BB5-EBDA70663B4BQ49790885-A55FE86F-22E3-4CA9-9608-A92B0471F9C4Q50028355-61BC4101-B5CD-40C3-9681-1488EA8D5642Q52430543-31C18271-2B7E-4774-A1E8-64B3740BB6FBQ52653329-6EAD20EF-31F0-4367-985E-2E1A47C86855Q52680700-8B90DE93-5E90-45EC-9B63-1EA2F8052940Q52725933-278BEAF9-0BF2-4C76-93EA-1D19E1399526Q55316265-60040FB4-A88F-49BB-9D8A-D11FF5D7E5A0Q55457087-017CA42F-10BC-4C92-A79B-01DEB02B3751Q58710816-756353A0-88FF-4742-A1E6-445A1A97D151Q58726533-31387E1B-423E-4961-8195-A9448737C3B7Q58756135-24188254-7AA1-4562-A283-1BFEF39A9210
P2860
BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
BET Bromodomain Proteins Funct ...... dependent of CDK9 Recruitment.
@en
BET Bromodomain Proteins Funct ...... dependent of CDK9 Recruitment.
@nl
type
label
BET Bromodomain Proteins Funct ...... dependent of CDK9 Recruitment.
@en
BET Bromodomain Proteins Funct ...... dependent of CDK9 Recruitment.
@nl
prefLabel
BET Bromodomain Proteins Funct ...... dependent of CDK9 Recruitment.
@en
BET Bromodomain Proteins Funct ...... dependent of CDK9 Recruitment.
@nl
P2093
P2860
P50
P1433
P1476
BET Bromodomain Proteins Funct ...... ndependent of CDK9 Recruitment
@en
P2093
Amanda Souza
Calla M Olson
Charles Y Lin
Christopher J Ott
Dennis L Buckley
Georg E Winter
Jaime M Reyes
James E Bradner
Joshiawa Paulk
Julia di Iulio
P2860
P304
P356
10.1016/J.MOLCEL.2017.06.004
P577
2017-06-29T00:00:00Z